author-photo

Elżbieta Senkus

Gdańsk Medical University

77

Papers

8554

Citations

Citation Trend

Filter By

Papers (65) Sort By

Journal Conference Others

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (61)
Abstract GS1-01: Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib combined with adjuvant endocrine therapy for high risk early breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib plus adjuvant endocrine therapy for high-risk early breast cancer

2021
Show All
- Source
- Cite
- Save
Citations (0)
De-escalation of axillary irradiation for early breast cancer - Has the time come?

2021 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (0)
Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib combined with adjuvant endocrine therapy for high risk early breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
Adjuvant Abemaciclib Combined With Endocrine Therapy for High-Risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis From the monarchE Study.

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (8)
Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer.

2021 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (1)
Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD.

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PD4-03: OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
ESO-ESMO 4(rd) International Consensus Guidelines for Breast Cancer in Young Women (BCY4).

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (63)